In this article, Phil Teare, Director of Computer Vision at AstraZeneca, provides insights on how computer vision is used in a biopharma setting and how cutting-edge explainable artificial intelligence (XAI) is crucial to what AstraZeneca does, and how they do it. You’ll also learn about how XAI has been rapidly evolving, and how much scientific value it really delivers.